Weiling He
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 8
- Cancer, Hypoxia, and Metabolism 6
- Oncology 23
- Co-authors
- Run Lin (8 shared papers)Zunfu Ke (12 shared papers)Yulong He (10 shared papers)Guohui Wan (6 shared papers)Arabella H. Wan (5 shared papers)Lei Sun (5 shared papers)Heng Liang (5 shared papers)Xianzhang Bu (4 shared papers)
- Journals
- Journal of Translational Medicine (3 papers)Cancer Research (2 papers)Theranostics (2 papers)International Journal of Biological Sciences (2 papers)Biomaterials Science (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Weiling He
91 papers receiving 4.1k citations
Weiling He's Hit Papers
Peers
Comparison fields: 5 of 143
- Cancer Research 1.0k
- Oncology 784
- Molecular Biology 1.8k
- Immunology 507
- Biomaterials 280
Countries citing papers authored by Weiling He
This map shows the geographic impact of Weiling He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiling He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiling He more than expected).
Fields of papers citing papers by Weiling He
This network shows the impact of papers produced by Weiling He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiling He. The network helps show where Weiling He may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiling He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global liver disease burdens and research trends: Analysis from a Chinese perspective Hit paper breakdown → | 2019 | 442 |
| 2 | RNA m6A methylation regulates sorafenib resistance in liver cancer through FOXO3‐mediated autophagy Hit paper breakdown → | 2020 | 377 |
| 3 | 2017 | 274 | |
| 4 | 2018 | 245 | |
| 5 | 2020 | 188 | |
| 6 | 2012 | 160 | |
| 7 | 2021 | 98 | |
| 8 | 2023 | 97 | |
| 9 | 2021 | 95 | |
| 10 | 2020 | 91 | |
| 11 | 2020 | 90 | |
| 12 | 2020 | 89 | |
| 13 | 2014 | 85 | |
| 14 | 2022 | 68 | |
| 15 | 2011 | 68 | |
| 16 | 2024 | 67 | |
| 17 | 2014 | 65 | |
| 18 | 2015 | 63 | |
| 19 | 2022 | 62 | |
| 20 | 2020 | 61 |
About Weiling He
Weiling He is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Biomaterials, having authored 92 papers that have together received 4.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (14 papers), Nanoplatforms for cancer theranostics (10 papers), Cancer-related molecular mechanisms research (8 papers), Gastric Cancer Management and Outcomes (8 papers), Cancer-related gene regulation (8 papers), Epigenetics and DNA Methylation (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Ferroptosis and cancer prognosis (6 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (784 citations), Molecular Biology (1.8k citations), Immunology (507 citations) and Biomaterials (280 citations). Weiling He has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Run Lin, Zunfu Ke, Yulong He, Guohui Wan, Arabella H. Wan, Lei Sun, Heng Liang, Xianzhang Bu, Yi Niu and Ziyou Lin. Their work appears in journals such as Journal of Translational Medicine, Cancer Research, Theranostics, International Journal of Biological Sciences and Biomaterials Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.